Pharma-Bio Serv (PBSV) Price to Book (2010 - 2026)

Pharma-Bio Serv (PBSV) has reported Price to Book for 17 consecutive years, with 1.04 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Price to Book rose 19.27% year-over-year to 1.04; the trailing twelve-month figure through Apr 2026 stood at 1.04 (up 19.27% YoY), and the FY2025 full-year result was 0.99, up 1.98% from the prior year.
• Price to Book declined to 1.04 in Q2 2026 per PBSV's latest filing, from 1.32 in the prior quarter.
• Across five years, Price to Book topped out at 1.56 in Q1 2024 and bottomed at 0.87 in Q2 2025.
• Historically, Price to Book has averaged 1.22 across 5 years, with a median of 1.2 in 2022.
• The sharpest annual moves came in 2023 and 2025: Price to Book jumped 36.97% in 2023, then slipped 28.55% in 2025.
• Over 5 years, Price to Book stood at 1.19 in 2022, then climbed by 1.57% to 1.21 in 2023, then decreased by 19.79% to 0.97 in 2024, then grew by 1.98% to 0.99 in 2025, then advanced by 4.8% to 1.04 in 2026.
• According to Business Quant data, Price to Book over the past three periods registered 1.04, 1.32, and 0.99 for Q2 2026, Q1 2026, and Q4 2025 respectively.